Poland
· Delayed Price · Currency is PLN Genomtec Company Description
Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally.
The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and other body fluids.
It also develops Genomtec Tumor, a SNAAT based solution used to identify neoplastic mutations and mutations with prognostic value in neoplastic disease; Genomtec SARS-CoV-2 EvaGreen and Direct-RT-LAMP CE-IVD Kit to detect SARS-CoV-2 RNA in various biological samples from patients with suspected COVID-19 infection; and Genomtec RT-LAMP CE-IVD Duo-Kit for the detection of all variants of the SARS-CoV-2 virus.
Genomtec S.A was founded in 2016 and is based in Wroclaw, Poland.
| Country | Poland |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Miron Tokarski |
Contact Details
Address: Bierutowska Street 57-59 Wroclaw, 51-317 Poland | |
| Phone | 48 793 440 931 |
| Website | genomtec.com |
Stock Details
| Ticker Symbol | GMT |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLGNMTC00017 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Miron Tokarski Ph.D. | Co-Founder, Chief Executive Officer and Member of the Management Board |
| Michal Wachowski | Chief Financial Officer and Member of the Management Board |
| Henryk Roguszczak | Co-founder and Chief Designer |
| Dr. Malgorzata Malodobra-Mazur | Co-founder and Director of Research and Development |
| Jarek Oleszczuk M.D., Ph.D. | C.B.O |